Insider trades
Thomas DiRaimondo, Chief Officer of Janux Therapeutics JANX, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $34.4K. The latest trade was on 01/02.
Thomas DiRaimondo
Chief Scientific Officer
- Company
- Janux Therapeutics JANX
- First filing
- 24/01/03
- Trades
- 8 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- −$34.4K
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/02 | 01/02 | 2,505 sh | $13.73 | $34,393.65 | −2.0% | |
JANX | Open-market sale10b5-1 plan | 24/09/27 | 24/09/27 | 5,000 sh2 trades | $46.35avg. | $231,731.75 | −4.9% |